Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Other Accumulated Expenses (2020 - 2021)

Design Therapeutics' Other Accumulated Expenses history spans 2 years, with the latest figure at $239000.0 for Q2 2021.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $239000.0 in Q2 2021 year-over-year; TTM through Jun 2021 was $239000.0, a N/A change, with the full-year FY2020 number at $100000.0, changed N/A from a year prior.
  • Other Accumulated Expenses hit $239000.0 in Q2 2021 for Design Therapeutics, up from $191000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for DSGN hit a ceiling of $239000.0 in Q2 2021 and a floor of $100000.0 in Q4 2020.